Skip to main content
. 2011 Jul 25;16(7):303–314. doi: 10.1186/2047-783X-16-7-303

Table 3.

Efficacy of different classes of anti-HCV agents with respect to resistance profile, genotype coverage and antiviral activity

NS3 Protease Inhibitors NS5A Inhibitors NS5B Nuc. Inhibitors NS5B Non-Nuc. Inhibitors Cyclophilin Inhibitors PEG-Interferon alfa
Barrier to resistance low low high low high very high
Genotype coverage + ++ +++ - ++ +++
antiviral activity +++ +++ ++ ++ +/++ +